About this medicine
- Approved name
- Xalatan
- International non-proprietary name (INN) or common name
- latanoprost
- Associated names
- Latanoprost Pharmacia & Upjohn
- Xalatan 50 mikrogramov/ml kaplijice za oko, raztopina
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/H/A-29 PAE/1270
- Type
- Article 29 paediatrics
This type of procedure may be triggered by a marketing-authorisation holder when applying for a new indication, new pharmaceutical form or new route of administration for use in children for a product authorised under Directive 2001/83/EC.
Key dates and outcomes
- CHMP opinion date
- 22/07/2010
- EC decision date
- 15/10/2010